ARK001 is a novel investigational treatment with a proprietary formulation for the treatment of infantile hemangioma (IH)

ARK001 Technology

  • Once-daily, easy-to-apply topical gel

  • Becomes a self-forming film that adheres to the IH

  • Formulated to deliver treatment directly to the IH for 24 hours

  • The treatment is rapidly deactivated by blood vessels in the skin, minimizing systemic exposure